CEPHALOSPORIUM ACREMONIUM (Allergy Laboratories, Inc.)
Welcome to the PulseAid listing for the CEPHALOSPORIUM ACREMONIUM drug offered from Allergy Laboratories, Inc.. This Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergy Laboratories, Inc. |
| NON-PROPRIETARY NAME: | acremonium strictum |
| SUBSTANCE NAME: | ACREMONIUM STRICTUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
| ROUTE: | PERCUTANEOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1967-12-07 |
| END MARKETING DATE: | 0000-00-00 |
CEPHALOSPORIUM ACREMONIUM HUMAN PRESCRIPTION DRUG Details:
| Item Description | CEPHALOSPORIUM ACREMONIUM from Allergy Laboratories, Inc. |
| LABELER NAME: | Allergy Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(g/20mL) |
| START MARKETING DATE: | 1967-12-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 54575-189_dbe7bebd-e445-4e59-8302-e706b795fbde |
| PRODUCT NDC: | 54575-189 |
| APPLICATION NUMBER: | BLA101376 |
Other ACREMONIUM STRICTUM Pharmaceutical Manufacturers / Labelers:
